# D3-GHR Polymorphism and Turner Syndrome

> **NCT00443144** · — · COMPLETED · sponsor: **University Hospital Tuebingen**

## Conditions studied

- Turner Syndrome
- Short Stature

## Interventions

- **DRUG:** recombinant human growth hormone

## Key facts

- **NCT ID:** NCT00443144
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-04
- **Final completion:** 2007-05
- **Target enrollment:** — (—)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00443144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00443144, "D3-GHR Polymorphism and Turner Syndrome". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00443144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*